HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong Yu Selected Research

JTE 013

7/2021Inhibition of sphingosine-1-phosphate receptor 2 attenuated ligature-induced periodontitis in mice.
4/2021Targeting S1PRs as a Therapeutic Strategy for Inflammatory Bone Loss Diseases-Beyond Regulating S1P Signaling.
1/2019Sphingosine-1-Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong Yu Research Topics

Disease

128Neoplasms (Cancer)
09/2022 - 04/2002
46Inflammation (Inflammations)
01/2022 - 11/2005
43Infections
09/2022 - 05/2003
20Hepatocellular Carcinoma (Hepatoma)
04/2022 - 06/2009
19Fibrosis (Cirrhosis)
01/2022 - 12/2003
19Atherosclerosis
01/2022 - 01/2006
18Myocardial Infarction
06/2022 - 01/2006
17Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 10/2006
16Breast Neoplasms (Breast Cancer)
10/2022 - 06/2004
16Hypoxia (Hypoxemia)
09/2022 - 12/2007
14Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2022 - 07/2008
14Carcinogenesis
01/2022 - 09/2004
13Obesity
06/2022 - 07/2002
13Body Weight (Weight, Body)
12/2020 - 07/2002
11Neoplasm Metastasis (Metastasis)
04/2022 - 08/2004
11Necrosis
02/2022 - 10/2000
11Pain (Aches)
08/2021 - 02/2002
11Carcinoma (Carcinomatosis)
07/2019 - 01/2008
10Ischemia
12/2021 - 04/2010
9Lung Neoplasms (Lung Cancer)
03/2022 - 06/2013
9Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 06/2014
9Hemorrhage
10/2021 - 04/2004
9Melanoma (Melanoma, Malignant)
09/2021 - 08/2006
9Leukemia
06/2015 - 03/2001
8Colorectal Neoplasms (Colorectal Cancer)
09/2022 - 01/2013
8Atrial Fibrillation
01/2022 - 03/2008
8Chronic Hepatitis B
06/2019 - 11/2005
8Chlamydia Infections
01/2017 - 02/2008
7Hyperglycemia
09/2022 - 03/2012
7Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 08/2004
7Prostatic Neoplasms (Prostate Cancer)
01/2019 - 06/2005
7Liver Cirrhosis (Hepatic Cirrhosis)
12/2014 - 11/2005
6Insulin Resistance
06/2022 - 06/2002
6Autism Spectrum Disorder
01/2022 - 01/2020
6Liver Diseases (Liver Disease)
12/2021 - 05/2003
6Esophageal Squamous Cell Carcinoma
11/2021 - 10/2012
6Infarction (Infarctions)
10/2020 - 01/2013
6Thrombosis (Thrombus)
01/2019 - 08/2004
6Pathologic Constriction (Stenosis)
07/2018 - 12/2006
5Adenocarcinoma of Lung
12/2022 - 08/2005
5Brain Neoplasms (Brain Tumor)
11/2022 - 01/2020
5COVID-19
11/2022 - 01/2020
5Schizophrenia (Dementia Praecox)
07/2022 - 09/2007
5Weight Loss (Weight Reduction)
06/2022 - 06/2007
5Lymphatic Metastasis
04/2022 - 01/2014
5Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2019
5Osteoarthritis
01/2022 - 02/2011
5Heart Failure
11/2021 - 03/2008
5Myocardial Ischemia (Ischemic Heart Diseases)
11/2021 - 01/2017
5Hypertension (High Blood Pressure)
03/2021 - 01/2012
5Stomach Neoplasms (Stomach Cancer)
02/2021 - 11/2012
5Weight Gain
01/2021 - 06/2007
5Wounds and Injuries (Trauma)
11/2020 - 02/2010
5Alzheimer Disease (Alzheimer's Disease)
01/2020 - 10/2008

Drug/Important Bio-Agent (IBA)

55Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2002
27Biomarkers (Surrogate Marker)IBA
05/2021 - 11/2005
24CytokinesIBA
06/2022 - 09/2004
21MicroRNAs (MicroRNA)IBA
11/2021 - 08/2009
19Messenger RNA (mRNA)IBA
01/2022 - 02/2007
19Pharmaceutical PreparationsIBA
01/2022 - 09/2005
18Long Noncoding RNAIBA
06/2022 - 12/2014
15Apolipoproteins E (ApoE)IBA
12/2021 - 01/2006
15VaccinesIBA
01/2020 - 03/2006
13CholesterolIBA
06/2022 - 05/2007
13DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2005
12LipidsIBA
01/2022 - 02/2011
12ApolipoproteinsIBA
12/2021 - 01/2006
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 09/2001
11Therapeutic UsesIBA
06/2022 - 01/2008
11AntigensIBA
01/2017 - 02/2002
10Small Interfering RNA (siRNA)IBA
11/2020 - 06/2010
9Peptides (Polypeptides)IBA
01/2018 - 08/2002
8Transcription Factors (Transcription Factor)IBA
11/2022 - 12/2007
8Glucose (Dextrose)FDA LinkGeneric
06/2022 - 06/2002
8CollagenIBA
04/2021 - 12/2012
8Interleukin-6 (Interleukin 6)IBA
01/2021 - 07/2010
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2018 - 10/2000
7AntibodiesIBA
09/2022 - 10/2002
7Biological ProductsIBA
01/2022 - 05/2005
6Insulin (Novolin)FDA Link
06/2022 - 06/2002
6RNA (Ribonucleic Acid)IBA
02/2022 - 08/2005
6Hormones (Hormone)IBA
01/2022 - 08/2006
6Antiviral Agents (Antivirals)IBA
01/2021 - 04/2009
6LeptinIBA
01/2021 - 07/2002
6Complement System Proteins (Complement)IBA
03/2015 - 01/2011
5ErbB Receptors (EGF Receptor)IBA
12/2022 - 11/2008
5Triglycerides (Triacylglycerol)IBA
06/2022 - 09/2015
5AnticoagulantsIBA
01/2022 - 01/2018
5Mitochondrial DNA (mtDNA)IBA
01/2022 - 03/2009
5CateninsIBA
01/2021 - 01/2014

Therapy/Procedure

74Therapeutics
07/2022 - 05/2003
21Drug Therapy (Chemotherapy)
10/2022 - 03/2007
18Radiotherapy
11/2022 - 04/2010
14Transplantation
03/2022 - 06/2012
11Stents
01/2022 - 12/2006
10Ligation
12/2021 - 08/2011
10Hepatectomy
10/2021 - 01/2005
9Deep Brain Stimulation
01/2018 - 07/2007
6Aftercare (After-Treatment)
04/2022 - 07/2010
5Length of Stay
10/2021 - 01/2011